People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs. optimal medical therapy alone in patients with CAD and HF. Intervention conferred ...

That’s the question at the heart of two perspectives published this week in Circulation: Cardiovascular Quality and Outcomes, with Rasha Al-Lamee, MBBS, PhD, and Christopher Rajkumar, MBBS (Imperial ...

Please provide your email address to receive an email when new articles are posted on . For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than ...

Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving ...

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters ...

Residual ischemic disease after PCI is associated with a significantly higher risk of major adverse cardiovascular events when compared with complete revascularization, according to data from a large ...

TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intracoronary imaging technologies, is pleased to highlight the recent publication in The ...